Abstract
Degeneration of lower motor neurons in the spinal cord and brain stem is a main phenomenon in ALS. These motor neurons occupy a remarkable position in that their cell bodies and dendrites are located within the central neurous system, whereas their axons constitute part of the peripheral nerves. The distal endings of the motor neurons in the motor end plates are unprotected by the blood-brain and blood-nerve barriers, and are therefore directly exposed to various substances in the blood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Conradi, L.-O. Ronnevi, and O. Vesterberg, Abnormal tissue distribution of lead in amyotrophic lateral sclerosis, J. Neurol. Sci., 29: 389–465 (1976).
S. Conradi, L.-O. Ronnevi, and O. Vesterberg, Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry, J. Neurol., Neurosurg. Psychiat., 41: 389–393 (1978).
H. G. J. M. Kuypers, Anatomy of the descending pathways, in: “The Nervous System”, Handbook of Physiology Section 1, V. B. Brooks, ed., vol. II, pp. 597–666 (1981).
S. Cullheim, J.-O. Kellerth, and S. Conradi, Evidence for direct synaptic interconnections between cat spinal alpha-motorneurons via the recurrent axon collaterals: a morphological study using intracellular injection of horseradish peroxidase, Brain Res., 132: 1–10 (1977).
S. Conradi, Functional implicance of the structure and synaptology of motor neurons in motor neuron disease, in: “Sensory-Motor Integration: Implications for Neurological Diseases”, A. Struppler and A. Weindl, eds., Springer (1986 - in press).
S. Conradi, L.-O. Ronnevi, and F. H. Norris, Motor neuron disease and toxic metals, in: “Human Motor Neuron Diseases”, L. P. Rowland, ed., pp. 201–229, Raven Press, New York (1982).
L.-O. Ronnevi, S. Conradi, and G. Nise, Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls: abnormal erythrocytes fragility in ALS, J. Neurol. Sci., 57: 143–156 (1982).
S. Galli, A. Sessa, et al. (this conference).
S. Conradi, and L.-O. Ronnevi, Cytotoxic factor in plasma from ALS patients provokes hemolysis of normal erythrocytes, Acta Neurol. Scand., 65 suppl., 90: 246–247 (1982).
S. Conradi, and L.-O. Ronnevi, Cytotoxic activity in the plasma of amyotrophic lateral sclerosis (ALS) patients against normal erythrocytes: quantitative determinations, J. Neurol. Sci., 68:135–145 (1985). 11.
L.-O. Ronnevi, S. Conradi, and E. Karlsson, Cytotoxic effects of immunoglobulins in amyotrophic lateral sclerosis, Acta Neurol. Scand., 69 suppl., 98: 182–183 (1984).
J. P. Antel, M. E. Medof, D. P. Richman, and B. G. W. Arnason, Immunological consideration in amyotrophic lateral sclerosis, in: “Clinical Neuro-immunology”, F. Clifford Rose, ed., pp. 22–44, Blackwell, Oxford (1979).
J. Digby, R. Harrison, A. Jehanli, C. G. Lunt, R. Capildeo, and F. Clifford Rose, Immunological changes in motor neurone disease, in: “Research Progress in Motor Neurone Disease”, F. Clifford Rose, ed., pp. 368–378, Pitman, Bath, UK (1984).
F. Roisen, H. Bartfield, D. Donnenfeld, and J. Baxter, Neuron specific in vitro cytotoxicity of sera from patients with amyotrophic lateral sclerosis, Muscle & Nerve, 5: 48–53 (1982).
F. Wolfgram, and L. Myers, Toxicity of serum from patients with ALS for anterior horn cells in vitro, Trans. Am. Neurol. Assoc., 97: 19–23 (1972).
J. Digby, R. Harrison, A. Jehanli, C. G. Lunt, and P. O. Behan, Motor neuron disease: binding of serum immunoglobulins to rat spinal cord neurones in culture, Proc. Vth Int. Congress on Neuromuscular Diseases, WE 37, Marseille (1982).
F. H. Norris, The riddle of positive immune system findings in amyotrophic lateral sclerosis, in: “Clinical Neuro-immunology”, F. Clifford Rose, ed., pp.245–258, Blackwell, Oxford.
J. Kelemen, Hedlund, J.-B. Orlin, E. M. Bekman, and T. L. Munsat, Plasmapheresis with immuno-suppression in amyotrophic lateral sclerosis, Arch. Neurol., 40: 752–753 (1983).
J. Monstad, J. Dale, C. F. Petlund, and O. Sjaastad, Plasma exchange in motor neuron disease: a controlled study, J. Neurol., 221: 59–66 (1979).
J. P. Conomy, G. Gerhard, H. Goren, W. Braun, and B. Barna, Plasma pheresis in the treatment of amyotrophic lateral sclerosis, Neurology, 30: 356 (1980).
V. Silani, G. Scarlato, G., G. Valli, and M. Marconi, Plasma exchange ineffective in amyotrophic lateral sclerosis, Arch. Neurol., 37: 511–513 (1980).
C. L. Schauf, J. P. Antel, B. G. W. Arnason, F. A. David, and M. W. Rooney, Neuroelectric blocking activity and plasmapheresis in amyotrophic lateral sclerosis, Neurology, 30: 1011–1013 (1980).
M. R. Olarte, R. S. Schoenfeldt, L. P. Rowland, et al., Plasmapheresis in amyotrophic lateral sclerosis, Ann. Neurol., 8: 644–645 (1980).
B. M. Patten, Neuropathy and motor neuron syndromes associated with plasma cell disease, Acta. Neurol. Scand., 69: 47–61 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Conradi, S., Ronnevi, LO. (1987). Immunoglobulin-Mediated Cytotoxic Effect of ALS-Plasma Towards Erythrocytes: Reflexion of a Pathogenetic Mechanism?. In: Cosi, V., Kato, A.C., Parlette, W., Pinelli, P., Poloni, M. (eds) Amyotrophic Lateral Sclerosis. Advances in Experimental Medicine and Biology, vol 209. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5302-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5302-7_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5304-1
Online ISBN: 978-1-4684-5302-7
eBook Packages: Springer Book Archive